Ventolin Evohaler, also known by its generic name salbutamol sulfate, is listed in the British National Formulary (BNF) under section 3.1.1.1 Selective Beta2-Agonists. Here’s a breakdown of the information you might find in the BNF about Ventolin Evohaler:

General Information:

• Classification: Selective Beta2-Agonist (SABA) for inhalation.




• Indications: The BNF will specify that Ventolin Evohaler is indicated for the relief of bronchospasm (narrowing of airways) in conditions like asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders.




• It can be used for:
  
  
  
  • Relieving symptoms of an asthma attack.

  
  

  • Preventing exercise-induced bronchoconstriction (tightening of airways during exercise).

  
  

  • As part of the maintenance treatment for some asthma cases.

  
  

  
  

Dosage:

• The BNF will provide a detailed breakdown of recommended dosage ranges for adults, children, and infants based on the specific use (relief or prevention).
  
  
  
  • This will likely include:
    
    
    
    • Adults and children (aged 12 years and over): 1-2 puffs for relief, up to 4 times a day. 2 puffs 10-15 minutes before exercise for prevention.

    
    

    • Children (aged 4-11 years): 1-2 puffs for relief, up to 4 times a day. Dosage for prevention will be specified by the doctor.

    
    

    • Infants (under 4 years): Dosage will be determined and closely monitored by a doctor.

    
    

    
    

  
  

  
  

Contraindications and Precautions:

• The BNF will outline situations where Ventolin Evohaler is not recommended, such as hypersensitivity to the medication or certain medical conditions like uncontrolled heart disease.




• Precautions for use will be listed, including potential interactions with other medications and warnings for specific patient groups (pregnant or breastfeeding women).

Side Effects:

• The BNF will provide a comprehensive list of potential side effects associated with Ventolin Evohaler, categorized by frequency. This might include:
  
  
  
  • Tremor (shaking)

  
  

  • Palpitations (fast heartbeat)

  
  

  • Headache

  
  

  • Dizziness

  
  

  • Mouth and throat irritation

  
  

  • Paradoxical bronchoconstriction (worsening of airway narrowing) in rare cases

  
  

  
  

Additional Information:

• The BNF entry might include details on:
  


• Special warnings, like not using the inhaler more frequently than prescribed.




• Information on storage and handling of Ventolin Evohaler.




• References to relevant clinical guidelines for asthma and COPD management.

Disclaimer:

This information is intended to give you a general idea of what the BNF entry for Ventolin Evohaler might contain. The BNF is a resource for healthcare professionals and may use technical language.

For the most up-to-date and specific information on Ventolin Evohaler, consult the official BNF or talk to your doctor.